Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Flashpoint Therapeutics
ChicagoBiotechnologyHealth CareTherapeuticsDescription
Flashpoint Therapeutics has announced the appointment of Venkat R Krishnamurthy, PhD, as Chief Scientific Officer. With over 15 years of experience in RNA therapeutics, Dr Krishnamurthy will lead research and development at Flashpoint.
Quick answer
Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy as Chief Scientific Officer (January 14, 2026). Flashpoint Therapeutics is based in Chicago, Illinois, United States.
- Who is the new Chief Scientific Officer at Flashpoint Therapeutics?
- Flashpoint Therapeutics named Venkat R. Krishnamurthy Chief Scientific Officer, announced January 14, 2026.
- What did Flashpoint Therapeutics announce on January 14, 2026?
- Flashpoint Therapeutics has announced the appointment of Venkat R Krishnamurthy, PhD, as Chief Scientific Officer. With over 15 years of experience in RNA therapeutics, Dr Krishnamurthy will lead research and development at Flashpoint.
- What does Flashpoint Therapeutics do?
- Flashpoint Therapeutics is at the forefront of drug discovery with its innovative structural nanomedicine platform.
- Where is Flashpoint Therapeutics based?
- Flashpoint Therapeutics is based in Chicago, Illinois, United States.
- Which similar companies made leadership changes around the same time?
- HaemaLogiX (January 15, 2026), Veristat (January 13, 2026), Emmecell (January 16, 2026) and BioMarin Pharmaceutical (January 12, 2026) also announced leadership changes within 45 days of Flashpoint Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- HaemaLogiX Appoints Dr Chris Baldwin as Chief Executive Officer (January 15, 2026)
- Veristat Appoints Kim McLean Boericke as Chief Executive Officer (January 13, 2026)
- Emmecell Appoints Ramin Valian as Chief Executive Officer (January 16, 2026)
- BioMarin Appoints Arpit Davé as Chief Digital and Information Officer (January 12, 2026)
- Spyre Therapeutics Appoints Kate Tansey Chevlen as Chief Commercial Officer (January 17, 2026)
- Enara Bio Appoints Scott Drutman as Chief Medical Officer (January 8, 2026)
Who to call at Flashpoint Therapeutics, and when
A new leader at Flashpoint Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Flashpoint Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Flashpoint Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Flashpoint Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Flashpoint Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Flashpoint Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.